ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Euro-Link Pharma Ltd

Euro-Link Pharma Ltd is an active company incorporated on 24 March 2014 with the registered office located in Luton, Bedfordshire. Euro-Link Pharma Ltd was registered 11 years ago.
Status
Active
Active since incorporation
Company No
08954858
Private limited company
Age
11 years
Incorporated 24 March 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 5 February 2025 (9 months ago)
Next confirmation dated 5 February 2026
Due by 19 February 2026 (3 months remaining)
Last change occurred 1 year 9 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2024 (1 year)
Accounts type is Micro Entity
Next accounts for period 31 March 2025
Due by 31 December 2025 (1 month remaining)
Address
72 Cardigan Street
Luton
LU1 1RR
Same address since incorporation
Telephone
08717818181
Email
Unreported
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in England • Born in Feb 1987
Director • Irish • Lives in England • Born in Mar 1970
A&S Pharma Holdings Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Ascenders Consulting Services Limited
Sharan Patel and Marc Anthony Hourigan are mutual people.
Active
Cygnus Pharma Ltd
Marc Anthony Hourigan is a mutual person.
Active
Hosm Marketing Limited
Marc Anthony Hourigan is a mutual person.
Active
A&S Pharma Holdings Ltd
Marc Anthony Hourigan is a mutual person.
Active
Farmak Pharmaceuticals UK Ltd
Marc Anthony Hourigan is a mutual person.
Active
Cape Pharmaceuticals Ltd
Sharan Patel is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Mar 2024
For period 31 Mar31 Mar 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
6
Increased by 3 (+100%)
Total Assets
£1.55M
Increased by £560.41K (+57%)
Total Liabilities
-£1.52M
Increased by £376K (+33%)
Net Assets
£26.94K
Increased by £184.41K (-117%)
Debt Ratio (%)
98%
Decreased by 17.72% (-15%)
Latest Activity
Confirmation Submitted
8 Months Ago on 19 Feb 2025
Micro Accounts Submitted
10 Months Ago on 30 Dec 2024
Farmak Pharmaceuticals Uk Ltd (PSC) Resigned
1 Year 1 Month Ago on 23 Sep 2024
A&S Pharma Holdings Ltd (PSC) Appointed
1 Year 1 Month Ago on 19 Sep 2024
Farmak Pharmaceuticals Uk Ltd (PSC) Appointed
1 Year 1 Month Ago on 19 Sep 2024
Sharan Patel (PSC) Resigned
1 Year 1 Month Ago on 19 Sep 2024
Sharan Patel Resigned
1 Year 1 Month Ago on 19 Sep 2024
Mr Marc Anthony Hourigan Appointed
1 Year 1 Month Ago on 19 Sep 2024
Charge Satisfied
1 Year 1 Month Ago on 19 Sep 2024
New Charge Registered
1 Year 8 Months Ago on 29 Feb 2024
Get Credit Report
Discover Euro-Link Pharma Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Confirmation statement made on 5 February 2025 with no updates
Submitted on 19 Feb 2025
Micro company accounts made up to 31 March 2024
Submitted on 30 Dec 2024
Memorandum and Articles of Association
Submitted on 6 Oct 2024
Resolutions
Submitted on 6 Oct 2024
Cessation of Farmak Pharmaceuticals Uk Ltd as a person with significant control on 23 September 2024
Submitted on 23 Sep 2024
Appointment of Mr Marc Anthony Hourigan as a director on 19 September 2024
Submitted on 23 Sep 2024
Notification of A&S Pharma Holdings Ltd as a person with significant control on 19 September 2024
Submitted on 23 Sep 2024
Termination of appointment of Sharan Patel as a director on 19 September 2024
Submitted on 23 Sep 2024
Cessation of Sharan Patel as a person with significant control on 19 September 2024
Submitted on 23 Sep 2024
Notification of Farmak Pharmaceuticals Uk Ltd as a person with significant control on 19 September 2024
Submitted on 23 Sep 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year